Acute bacterial osteoarticular infections: Eight-year analysis of C-reactive protein for oral step-down therapy

Pediatrics

Volumn 130, Issue 4, 2012, Pages

  Arnold, John C ^a,b   Cannavino, Christopher R ^b,c   Ross, Mindy K ^b   Westley, Ben ^d   Miller, Thomas C ^a   Riffenburgh, Robert H ^a   Bradley, John ^b,c  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

Acute bacterial arthritis; Acute bacterial osteomyelitis; C reactive protein; CRP; Osteomyelitis; Septic arthritis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CLINDAMYCIN; COTRIMOXAZOLE; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL INFECTION; BACTERIUM CULTURE; CHILD; CLINICAL FEATURE; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTRONIC MEDICAL RECORD; FEMALE; HALF LIFE TIME; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOMYELITIS; PARENTERAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT RESPONSE;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; DECISION SUPPORT TECHNIQUES; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; OSTEOMYELITIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84867146939     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-0220     Document Type: Article

References (29)

1. Zaoutis T, Localio AR, Leckerman K, Saddlemire S, Bertoch D, Keren R. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123(2):636-642
2. Syrogiannopoulos GA, Nelson JD. Duration of antimicrobial therapy for acute suppurative osteoarticular infections. Lancet. 1988;1(8575-8576):37-40 (Pubitemid 18017214)
3. Williams DJ, Deis JN, Tardy J, Creech CB. Culture-negative osteoarticular infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2011;30(6):523-525
4. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52(4):561-571
5. Kushner I, Ballou S. Acute-Phase Reactants and the Concept of Inflammation. 8th ed. Philadelphia, PA: WB Saunders Co; 2008
6. Peltola H, Pääkkönen M, Kallio P, Kallio MJ; Osteomyelitis-Septic Arthritis (OM-SA) Study Group. Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis. 2009;48(9):1201-1210
7. Peltola H, Unkila-Kallio L, Kallio MJ; The Finnish Study Group. Simpli fied treatment of acute staphylococcal osteomyelitis of childhood. Pediatrics. 1997;99(6):846-850 (Pubitemid 27231358)
8. Peltola H, Vahvanen V, Aalto K. Fever, C-reactive protein, and erythrocyte sedimentation rate in monitoring recovery from septic arthritis: a preliminary study. J Pediatr Orthop. 1984;4(2):170-174 (Pubitemid 14167700)
9. Nelson JD, Bucholz RW, Kusmiesz H, Shelton S. Benefits and risks of sequential parenteral - oral cephalosporin therapy for suppurative bone and joint infections. J Pediatr Orthop. 1982;2(3):255-262 (Pubitemid 13101998)
10. Nelson JD, Norden C, Mader JT, Calandra GB. Evaluation of new anti-infective drugs for the treatment of acute hematogenous osteomyelitis in children. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992;15 (suppl 1):S162-S166
11. Bryson YJ, Connor JD, LeClerc M, Giammona ST. High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children. J Pediatr. 1979;94(4):673-675 (Pubitemid 9125382)
12. Dagan R. Management of acute hematogenous osteomyelitis and septic arthritis in the pediatric patient. Pediatr Infect Dis J. 1993;12(1):88-92
13. Gutierrez K. Bone and joint infections in children. Pediatr Clin North Am. 2005;52(3):779-794, vi (Pubitemid 40733594)
14. Kolyvas E, Ahronheim G, Marks MI, Gledhill R, Owen H, Rosenthall L. Oral antibiotic therapy of skeletal infections in children. Pediatrics. 1980;65(5):867-871 (Pubitemid 10068339)
15. Rodriguez W, Ross S, Khan W, McKay D, Moskowitz P. Clindamycin in the treatment of osteomyelitis in children: a report of 29 cases. Am J Dis Child. 1977;131(10):1088-1093
16. Tetzlaff TR, McCracken GH Jr, Nelson JD. Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr. 1978;92(3):485-490 (Pubitemid 8296517)
17. Kaplan SL, Mason EO Jr, Feigin RD. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. South Med J. 1982;75(2):138-142 (Pubitemid 12128106)
18. Peltola H, Pääkkönen M, Kallio P, Kallio MJ; Osteomyelitis-Septic Arthritis Study Group. Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases. Pediatr Infect Dis J. 2010;29(12):1123-1128
19. Gonzalez BE, Teruya J, Mahoney DH Jr et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006;117(5):1673-1679 (Pubitemid 46071396)
20. Arnold SR, Elias D, Buckingham SC, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop. 2006;26(6):703-708 (Pubitemid 44655534)
21. Bocchini CE, Hulten KG, Mason EO Jr, Gonzalez BE, Hammerman WA, Kaplan SL. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006;117 (2):433-440 (Pubitemid 46071606)
22. Hawkshead JJ III, Patel NB, Steele RW, Heinrich SD. Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus. J Pediatr Orthop. 2009;29(1):85-90
23. Nourse C, Starr M, Munckhof W. Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health. 2007;43(10):656-661 (Pubitemid 47390255)
24. Saavedra-Lozano J, Mejías A, Ahmad N, et al. Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections. J Pediatr Orthop. 2008;28(5):569-575
25. Chang FY, Peacock JE Jr, Musher DM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003;82(5):333-339 (Pubitemid 37229468)
26. Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother. 2003;51(5):1261-1268 (Pubitemid 36622083)
27. Lo WT, Wang CC, Lin WJ, et al. Changes in the nasal colonization with methicillin-resistant Staphylococcus aureus in children: 2004-2009. PLoS ONE. 2010;5(12):e15791
28. McCaskill ML, Mason EO Jr, Kaplan SL, Hammerman W, Lamberth LB, Hultén KG. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J. 2007;26(12):1122-1127 (Pubitemid 350190944)
29. Gerber JS, Cof fi n SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children 's hospitals in the United States. Clin Infect Dis. 2009;49(1):65-71